The present work argues for the involvement of the zinc chelating ability of some non-steroidal anti-inflammatory drugs as an additive mechanism able to increase their efficacy against COVID-19.

Hypothesis: Efficacy of early treatments with some NSAIDs in COVID-19: Might it also depend on their direct and/or indirect zinc chelating ability?

Zamai, Loris
Conceptualization
2023

Abstract

The present work argues for the involvement of the zinc chelating ability of some non-steroidal anti-inflammatory drugs as an additive mechanism able to increase their efficacy against COVID-19.
File in questo prodotto:
File Dimensione Formato  
British J Pharmacology - 2022 - Zamai - Hypothesis Efficacy of early treatments with some NSAIDs in COVID‐19 Might it.pdf

accesso aperto

Tipologia: Versione editoriale
Licenza: Creative commons
Dimensione 448.71 kB
Formato Adobe PDF
448.71 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11576/2707430
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact